Trade Summary

7 months ago, Salkind Gene, serving as Dir at Upexi, Inc. (UPXI), purchased 200,000 shares at $2.73 per share, for a total transaction value of $546,000.00. Following this transaction, Salkind Gene now holds 738,220 shares of UPXI.

This purchase represents a 37.00% increase in Salkind Gene's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, November 17, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, November 18, 2025 at 4:40 PM ET, 1 day after the trade was made.

Upexi, Inc. operates in the COMMUNICATION SERVICES sector, specifically within the INTERNET CONTENT & INFORMATION industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.